Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Recruiting 4Not yet recruiting 2Active not recruiting 2Unknown 1Enrolling by invitation 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Leukemia, Lymphocytic, Chronic, B-Cell 6Neoplasms 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 4Multiple Myeloma 4Recurrence 3Pain 3Lymphoma, B-Cell 3Hematologic Neoplasms 3Anxiety Disorders 3Prostatic Neoplasms 2Lymphoproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lung Neoplasms 2Leukemia, B-Cell 2Leukemia 2Irritable Bowel Syndrome 2Hypertension 2Hodgkin Disease 2Depression 2Dementia 2Cognitive Dysfunction 2Atrial Fibrillation 2Asthma 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Cytokine Release Syndrome × Lymphoid × Clear all
NCT07499128 2026-06-01

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
136 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡